@hemehub.bsky.social🩸 Facts about Smoldering Multiple Myeloma:
The PANGEA risk model, key progression biomarkers, limitations of static risk models, and progression risk across low-, intermediate-, and high-risk SMM.
#SMM #SmolderingMultipleMyeloma #MultipleMyeloma #Hematology #HemeOnc #HemeHub
@hemehub.bsky.social🩸 HemeHub is honored to have Adam Cuker, MD, MS, on our Scientific Advisory Board.
A leader in hematology, Dr. Cuker brings expertise in hemophilia, thrombosis, and blood disorders to help advance HemeHub’s mission.
#HemeHub #Hematology #Hemophilia #Thrombosis #BloodDisorders
@hemehub.bsky.social🌟 Our DLBCL case discussion with Sairah Ahmed, MD, and Elif Yilmaz, MD is now available to watch on YouTube!
⮕ Watch the full session: youtu.be/EMPaDlO5lto
@hemehub.bsky.social🎯Today’s questions!
Swipe to see the answers and explanations!
#SMM #SmolderingMultipleMyeloma #MultipleMyeloma #Hematology #HemeOnc #Oncology #MedicalEducation #MedEd #ClinicalHematology #Genomics #HemeHub
@hemehub.bsky.social🩸 Facts about Smoldering Multiple Myeloma:
Key SMM risk models include Mayo 2008, PETHEMA, IMWG 20/2/20, cytogenetic risk refinement, and the MGUS-like phenotype.
#SMM #SmolderingMultipleMyeloma #MultipleMyeloma #Hematology #HemeOnc #HemeHub
@hemehub.bsky.social🌟 Registration for the HemeHub Hematology Summit is filling quickly!
🗓️ October 3, 2026
📍 Gaylord Texan Resort & Convention Center
Registration: hemehub.org/events/hemeh...
#HemeHub #HemeOnc #Hematology #HematologySummit #MedicalEducation #Oncology
@hemehub.bsky.socialHappening next Friday!
⮕ Register: hemehub.org/live-webinars
#SmolderingMyeloma #MultipleMyeloma #Myeloma #Hematology #HemOnc #Oncology #MedicalEducation #MedEd #HemeHub
@hemehub.bsky.social🚀💡Today’s questions!
Swipe to see the answers and explanations!
#SMM #SmolderingMultipleMyeloma #MultipleMyeloma #Hematology #HemeOnc #Oncology #MedicalEducation #MedEd #ClinicalHematology #HemeHub #Daratumumab #AQUILA #CENTAURUS
@hemehub.bsky.social🩸 Facts about Smoldering Multiple Myeloma:
SLIM-CRAB criteria, precursor stages, immunoparesis, evolving biomarkers, and circulating tumor cells all play a role in assessing SMM progression risk.
#SMM #SmolderingMultipleMyeloma #MultipleMyeloma #Hematology #HemeOnc #HemeHub
@hemehub.bsky.social🌟🎯First clinical questions of the month!
Swipe to see the answers and explanations!
#SMM #SmolderingMultipleMyeloma #MultipleMyeloma #Myeloma #PlasmaCellDisorders #MGUS #IMWG #Hematology #HemeOnc #Oncology #ClinicalHematology #MedicalEducation #MedEd #HemeHub
@hemehub.bsky.social🩸📢 The links for the HemeHub Hematology Summit have been updated!
Registration: hemehub.org/events/hemeh...
Full program and event details:
hemehub.org/events/hemeh...
🗓️ October 3, 2026
📍 Gaylord Texan Resort & Convention Center
#HemeHub #HemeOnc #Myelofibrosis #MultipleMyeloma #CLL #PNH #DLBCL
@hemehub.bsky.social🌟 We’re honored to welcome Ayalew Tefferi, M.D., to the HemeHub Hematology Summit!
Dr. Tefferi is a Mayo Clinic hematology expert specializing in myeloproliferative neoplasms.
🎙️ Session Topic: Myelofibrosis
🔗 Register: hemehub.org/events/hemeh...
#HemeHub #HematologySummit #HemeOnc#Myelofibrosis
@hemehub.bsky.social🩸🌎 HemeHub’s recorded webinars on YouTube have reached viewers in 65 countries worldwide, including Belarus, Uganda, Georgia, Kazakhstan, and many more.
Thank you to our growing global community for joining us!
🌐 Learn more: hemehub.org
#HemeHub #Hematology #Oncology #MedEd #GlobalHealth #HemeOnc
@hemehub.bsky.social🌟 Faculty Spotlight | HemeHub Hematology Summit
Introducing Leo I. Gordon, MD, Professor of Medicine and Oncology Research at Northwestern University Feinberg School of Medicine.
🔗 Register today: hemehub.org/hybrid-event...
@hemehub.bsky.social📢HemeHub Hematology Summit is almost here!
Join us for key updates and evolving treatment strategies in hematologic diseases.
🗓️October 3, 2026
📍 Gaylord Texan Resort & Convention Center
🔗 Register: hemehub.org/hybrid-events/hematology-summit
@hemehub.bsky.social🩸This Month on HemeHub: Smoldering Multiple Myeloma
Explore risk stratification, evolving biomarkers, and emerging treatment approaches for high-risk SMM.
🎙️Live Webinar: Shaji Kumar, MD & Adeel Khan, MD — This Friday!
@hemehub.bsky.social🩸 Happening this Friday!
⮕ Register: hemehub.org/live-webinars
⮕ Submit your cases: hemehub.org/case-submiss...
#SmolderingMyeloma #MultipleMyeloma #Hematology #HemOnc #Oncology #MedEd #HemeHub